share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

EyePoint Pharmaceuticals | 4:持股变动声明-高管 Duker Jay S.
美股SEC公告 ·  07/12 17:08
Moomoo AI 已提取核心信息
EyePoint Pharmaceuticals, Inc. (EYPT) President and CEO, Jay S. Duker, completed a stock transaction on July 10, 2024. Duker exercised options to acquire 16,666 shares of common stock at no cost and subsequently sold 8,059 shares at a price of $8.69 per share. The total market value of the disposed shares amounted to $70,032.71. Following these transactions, Duker directly holds 38,027 shares of EyePoint Pharmaceuticals. Additionally, an indirect holding of 22,500 shares is maintained by a family trust.
EyePoint Pharmaceuticals, Inc. (EYPT) President and CEO, Jay S. Duker, completed a stock transaction on July 10, 2024. Duker exercised options to acquire 16,666 shares of common stock at no cost and subsequently sold 8,059 shares at a price of $8.69 per share. The total market value of the disposed shares amounted to $70,032.71. Following these transactions, Duker directly holds 38,027 shares of EyePoint Pharmaceuticals. Additionally, an indirect holding of 22,500 shares is maintained by a family trust.
EyePoint Pharmaceuticals (眼点药业)的总裁兼CEO Jay S. Duker在2024年7月10日完成了一笔股票交易。Duker行使了期权以免费获得16,666股普通股,并随后以每股8.69美元的价格出售了8,059股。被处置股份的总市值为70,032.71美元。完成这些交易后,Duker直接持有38,027股EyePoint Pharmaceuticals的股份。此外,一个家庭信托拥有22,500股的间接持有。
EyePoint Pharmaceuticals (眼点药业)的总裁兼CEO Jay S. Duker在2024年7月10日完成了一笔股票交易。Duker行使了期权以免费获得16,666股普通股,并随后以每股8.69美元的价格出售了8,059股。被处置股份的总市值为70,032.71美元。完成这些交易后,Duker直接持有38,027股EyePoint Pharmaceuticals的股份。此外,一个家庭信托拥有22,500股的间接持有。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息